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Paying for Terminal Illness
The experience of dying has moved
from a private family matter to the
public professional sphere. Medicare
hospice coverage is intended to be com-
prehensive, but its eligibility rules and
per diem limits deprive some patients
of needed care. This article examines
these limits and the alternative models
for care of the dying.
By Journal Staff
he vocal public debate over the right to
determine one's own way of dying
must, first or last, depend upon soci-
ety's willingness to pay for terminal
care-whatever that is to include.
The experience of dying has changed over
recent decades. The need for assistance from soci-
ety results in part from the fact that death itself has
moved from a private family matter to the public
professional sphere.
As late as 1939, less than half of the population
died in hospitals, nursing homes, or other institu-
tions. By 1992, over 80 percent did so.' The dying
came to be separated from their home environ-
ments and people, and placed in the care of profes-
sionals with a commitment to institutional and
professional values that might conflict sharply with
the patient's preferences. At the least, institutional
dying caused patients and family a regrettable loss
of privacy and intimacy at a sensitive time.
In the early 1980s, perhaps a thousand hospices
existed nationwide. Mostly small, they were fund-
ed with payments from patients, charities, and pri-
vate and public grants. In 1983, Congress created
the Medicare hospice benefit to provide broad
medical and social services benefits, including
home health services, outpatient drugs for pain
control, physician services, counseling, and short-
term residential care in a skilled nursing facility or
a hospital. Core services are provided 24 hours a
day. The emphasis is on palliative care, defined as
diagnostic and therapeutic intervention intended to
relieve pain and other symptoms but without the
goal of prolonging life.2
The beneficiary who elects hospice care forgoes
Medicare benefits intended to treat the terminal ill-
ness. The beneficiary must have a diagnosis pro-
jecting death within six months to qualify to make
the election, and can opt to return to Medicare cov-
erage under Parts A and B to receive curative treat-
ment.
Medicare hospice care involves few copay-
ments. The beneficiary is responsible for a copay-
ment on each prescription filled of the lesser of $15
or 5 percent of cost. There is also a copayment for
inpatient respite care.
Prior to the Balanced Budget Act of 1997, the
Medicare hospice benefit consisted of two 90-day
periods and one additional period of 30 days, with
27
Elder's Advisor
an extension of care for the rest of the patient's
life.' The Balanced Budget Act provided for two
90-day periods followed by an unlimited number
of 60-day periods. At the beginning of each 60-day
period, a hospice physician must certify that the
patient has a terminal illness with death anticipat-
ed within six months.
The structure of hospice care has posed prob-
lems for patients and for the program's successful
expansion. The 210-day stay is based on typical
needs of cancer patients, hospice's traditional tar-
get group. Advocates have pointed out that the
structure of benefits is unsuited to the needs of
many, such as those with chronic obstructive pul-
monary disease whose prognosis is unpredictable.
Other chronic, and ultimately fatal, conditions
have an acute phase during which hospice-type ser-
vices might be needed and death might seem immi-
nent, only to have severe symptoms go into remis-
sion. For these patients, the hospice eligibility peri-
od might be too short. Even the 60-day extensions
imply predictability that is frequently lacking.
For other dying patients, hospice care might
come too late, so the stay is too short to serve hos-
pice goals of physical, psychological, and spiritual
comfort for patients and their families. The patient
and family members must become familiar with the
professional visitors to the home in order to learn
and benefit from their experiences and knowledge.
Yet, the average length of certification for hospice
care dropped throughout the past decade, from
over two months to less than 20 days in one study.
Although a three-month stay may be considered
optimum for hospice goals, one study reported the
median survival time for hospice patients to be 36
days. 4 Further, only about 17 percent of dying per-
sons use a hospice program.
Capped per diem payments to hospices also are
suspect, although the full picture of their impact is
unclear. Medicare pays hospices using four levels of
per diem rates plus an overall cap. In 1997, the cap
was $13,974 times the number of enrolled patients.
The per diem rate for routine home care was
$94.17. The Institute of Medicine noted that cer-
tain kinds of care, including the use of costly pain
medications, late-night visits for medical or emo-
tional crises, and use of high-tech equipment might
be precluded by the rate.'
Extended low-tech services might also be
impossible under the home care per diem. Family
members learn home care skills from visiting nurs-
es and provide much of the round-the-clock care.
While it is typical to provide a home health aide to
be by the bedside when death is imminent, the per
diem cap precludes extended periods of attendance
needed by those without family caregivers.
Soon after creation of the Medicare hospice,
and partly in reaction to the government's defini-
tion of hospice care, the Cleveland clinics estab-
lished a Palliative Care Program, defining palliative
care as the "total act of care of patients whose dis-
ease is not curable." The program incorporated
inpatient and outpatient services with home health
care, without time limits. In a program new in the
1990s, payer and patient preference for home care
is emphasized at the Center to Improve Care of the
Dying at George Washington University. The pro-
gram emphasizes comprehensive community-based
services, including family support. These are just
two of the well-developed models that might pro-
vide direction for new hospice policy.
Hospice programs were scrutinized in recent
years for services to patients who were not reason-
ably considered to be terminal. Those with clients
reaching the end of life can envision how this hap-
pens: The assisted living or condominium dweller
with chronic illness has a period of acute distress,
perhaps is briefly hospitalized, and returns home
with patient, doctors, and family considering
"Maybe it would be better if . . ." Since extensive
practical and counseling assistance is helpful, and
needed prescriptions are less costly to the patient,
he or she "elects" hospice care. And then the
patient rallies, proving life is very strong even for
those who are old and ill.
Hospice has been a managed-care "carve-out,"
that is, left out of the package of benefits covered
by Medicare managed care. Perhaps the principal
justification is the difficulty of incorporating pay-
ment for a hospice with payment for life-extending
health care. The resolution of incompatible values
and methods for health care and hospice care is not
yet clear.
Yet, there are a number of observations that
might improve the hospice benefit and experience:
Better pain management is critical. Conservative
medical boards in many states have censured
their doctors for liberal use of pain medication,
erroneously identifying all generous use with
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misuse and addiction. Such concerns are inap-
propriate for terminal patients. Yet, the artful
use of pain medications for the chronically ill
and dying has not been well studied. Nor is it
taught in medical schools.
The conflict of values between acute medical
care and palliative care of the dying must be
resolved. The principal difficulty arises, it
seems, from the relatively recent inability of
physicians to discern when medical technology
can assist the patient. The decision is compli-
cated by the patient's personality and wishes,
unmeasurable factors such as the perception of
pain, and uncertainty about the outcome of
medical procedures on patients who are already
old and ill.
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